


Healthcare News Roundup: FDA
HSMN NewsFeed - 29 Jun 2021
Inova Diagnostics Announces FDA 510(k) Clearance for Aptiva(R), a Digital Multi-Analyte System
Inova Diagnostics Announces FDA 510(k) Clearance for Aptiva(R), a Digital Multi-Analyte System
HSMN NewsFeed - 29 Jun 2021
Interventional Systems Receives FDA Clearance for its All-around Miniature Medical Robot
Interventional Systems Receives FDA Clearance for its All-around Miniature Medical Robot
HSMN NewsFeed - 17 Jun 2021
Irrimax Receives FDA Clearance for Irrisept(R) as an Antimicrobial Wound Lavage for US Market
Irrimax Receives FDA Clearance for Irrisept(R) as an Antimicrobial Wound Lavage for US Market
HSMN NewsFeed - 14 Jun 2021
FDA Clears LPCN 1154 IND Application for a Phase 2 Postpartum Depression Study
FDA Clears LPCN 1154 IND Application for a Phase 2 Postpartum Depression Study
HSMN NewsFeed - 10 Jun 2021
Nuvo Group Receives 510(k) FDA Clearance for Remote Monitoring of Uterine Activity
Nuvo Group Receives 510(k) FDA Clearance for Remote Monitoring of Uterine Activity
HSMN NewsFeed - 7 Jun 2021
FDA Approves First-of-its-Kind SenSight(TM) Directional Lead System for DBS Therapy
FDA Approves First-of-its-Kind SenSight(TM) Directional Lead System for DBS Therapy
HSMN NewsFeed - 24 May 2021
EndoFresh Obtains FDA 510(k) Clearance for Its Groundbreaking Disposable Digestive Endoscopy System
EndoFresh Obtains FDA 510(k) Clearance for Its Groundbreaking Disposable Digestive Endoscopy System
HSMN NewsFeed - 14 May 2021
FDA Responds to Creative Medical Technology Holdings Regarding Its ImmCelz(R) IND for Stroke Treatment
FDA Responds to Creative Medical Technology Holdings Regarding Its ImmCelz(R) IND for Stroke Treatment
HSMN NewsFeed - 11 May 2021
FDA Grants Bold Therapeutics' BOLD-100 an Orphan Drug Designation (ODD) in the Treatment of Gastric Cancer
FDA Grants Bold Therapeutics' BOLD-100 an Orphan Drug Designation (ODD) in the Treatment of Gastric Cancer
